EA199800593A1 - Микрогранулы с пролонгированным высвобождением, содержащие дилтиазем в качестве активного ингредиента - Google Patents

Микрогранулы с пролонгированным высвобождением, содержащие дилтиазем в качестве активного ингредиента

Info

Publication number
EA199800593A1
EA199800593A1 EA199800593A EA199800593A EA199800593A1 EA 199800593 A1 EA199800593 A1 EA 199800593A1 EA 199800593 A EA199800593 A EA 199800593A EA 199800593 A EA199800593 A EA 199800593A EA 199800593 A1 EA199800593 A1 EA 199800593A1
Authority
EA
Eurasian Patent Office
Prior art keywords
active ingredient
prolonged
survent
micrograwns
diltiaze
Prior art date
Application number
EA199800593A
Other languages
English (en)
Other versions
EA001721B1 (ru
Inventor
Патрис Дебрежа
Жерар Ледюк
Паскаль Ури
Паскаль Сюпли
Original Assignee
Лаборатуар Де Продюи Этик Этифарм
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9485856&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA199800593(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Лаборатуар Де Продюи Этик Этифарм filed Critical Лаборатуар Де Продюи Этик Этифарм
Publication of EA199800593A1 publication Critical patent/EA199800593A1/ru
Publication of EA001721B1 publication Critical patent/EA001721B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

Описаны новые формы микрогранул с пролонгированным высвобождением активного ингредиента (ПВА), содержащих дилтиазем. Микрогранулы состоят из нейтрального гранулированного носителя, покрытого активным слоем, включающим дилтиазем или его фармацевтически приемлемую соль в качестве активного ингредиента, поверхностно-активное вещество и связующее, и внешним слоем, обеспечивающим пролонгированное высвобождение активного ингредиента (слой ПВА).Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199800593A 1995-12-22 1996-12-23 Микрогранулы с пролонгированным высвобождением, содержащие дилтиазем в качестве активного ингредиента EA001721B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9515361A FR2742660B1 (fr) 1995-12-22 1995-12-22 Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
PCT/FR1996/002040 WO1997023219A1 (fr) 1995-12-22 1996-12-23 Microgranules a liberation prolongee contenant du diltiazem comme principe actif

Publications (2)

Publication Number Publication Date
EA199800593A1 true EA199800593A1 (ru) 1998-12-24
EA001721B1 EA001721B1 (ru) 2001-08-27

Family

ID=9485856

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199800593A EA001721B1 (ru) 1995-12-22 1996-12-23 Микрогранулы с пролонгированным высвобождением, содержащие дилтиазем в качестве активного ингредиента

Country Status (27)

Country Link
US (3) US6228395B1 (ru)
EP (1) EP0868184B1 (ru)
JP (1) JP2000506500A (ru)
KR (1) KR100354054B1 (ru)
CN (1) CN1145488C (ru)
AR (1) AR004410A1 (ru)
AT (1) ATE238798T1 (ru)
AU (1) AU721949B2 (ru)
BG (1) BG63770B1 (ru)
BR (1) BR9612225A (ru)
CA (1) CA2242224C (ru)
DE (1) DE69627880T2 (ru)
DK (1) DK0868184T3 (ru)
EA (1) EA001721B1 (ru)
EE (1) EE04045B1 (ru)
ES (1) ES2198505T3 (ru)
FR (1) FR2742660B1 (ru)
GE (1) GEP20022629B (ru)
HK (1) HK1018400A1 (ru)
HU (1) HU224214B1 (ru)
IL (1) IL125047A (ru)
NO (1) NO324680B1 (ru)
NZ (1) NZ324739A (ru)
PL (1) PL186621B1 (ru)
PT (1) PT868184E (ru)
WO (1) WO1997023219A1 (ru)
ZA (1) ZA9610776B (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2742660B1 (fr) * 1995-12-22 1998-04-03 Ethypharm Lab Prod Ethiques Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
US6162463A (en) * 1997-05-01 2000-12-19 Dov Pharmaceutical Inc Extended release formulation of diltiazem hydrochloride
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
EP1064938A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmaceutical dosage forms for controlled release producing at least a timed pulse
EP1064937A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
US7179483B2 (en) 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
FR2831546B1 (fr) * 2001-10-31 2007-03-23 Atofina Materiau polymere thermoplastique pour supports d'enregistrement d'informations audio et/ou optiques
BRPI0415242B8 (pt) * 2003-10-10 2021-05-25 Ethypharm Sa microgrânulos de liberação gradual contendo extrato de gingko biloba e o processo para fabricar estes
US20070122471A1 (en) * 2003-12-25 2007-05-31 Takeda Pharmaceutical Company Limited Method of improving suitability for granulation
JP2005306778A (ja) * 2004-04-21 2005-11-04 Basf Ag 徐放性製剤及びその製造方法
WO2006013431A1 (en) * 2004-07-29 2006-02-09 Pfizer Limited Stable controlled-release pharmaceutical formulation of eletriptan
US8778395B2 (en) * 2005-08-11 2014-07-15 Andrx Labs, Llc Diltiazem controlled release formulation and method of manufacture
KR101486228B1 (ko) * 2006-06-19 2015-01-26 알파마 파머슈티컬스 엘엘씨 약제학적 조성물
ITFI20110172A1 (it) 2011-08-08 2013-02-09 Valpharma Sa Formulazione multiparticolata a rilascio modificato di diltiazem hcl.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale
DK173505B1 (da) * 1987-02-20 2001-01-15 Pharmatec Internat S R L Fremgangsmåde til fremstilling af en diltiazempellet med langsom afgivelse og anvendelse af således fremstillede pelleter t
JPH07552B2 (ja) * 1987-11-06 1995-01-11 田辺製薬株式会社 持効性製剤
FR2623714B1 (fr) * 1987-11-26 1990-04-20 Ethypharm Sa Forme a liberation prolongee du diltiazem, et son medicament ainsi obtenu
FR2624732B1 (fr) * 1987-12-21 1991-02-15 Synthelabo Formulation pharmaceutique a liberation prolongee
FR2630647B1 (fr) * 1988-04-27 1991-08-16 Sanofi Sa Microbilles de diltiazem, leur procede de fabrication et compositions pharmaceutiques a liberation prolongee les contenant
US5288505A (en) 1991-06-26 1994-02-22 Galephar P.R., Inc., Ltd. Extended release form of diltiazem
US5229135A (en) * 1991-11-22 1993-07-20 Prographarm Laboratories Sustained release diltiazem formulation
US5376384A (en) 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
US5834024A (en) * 1995-01-05 1998-11-10 Fh Faulding & Co. Limited Controlled absorption diltiazem pharmaceutical formulation
FR2742660B1 (fr) * 1995-12-22 1998-04-03 Ethypharm Lab Prod Ethiques Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif

Also Published As

Publication number Publication date
IL125047A (en) 2003-05-29
BG63770B1 (bg) 2002-12-29
HUP9904129A3 (en) 2000-11-28
ES2198505T3 (es) 2004-02-01
US6660296B2 (en) 2003-12-09
HK1018400A1 (en) 1999-12-24
US6228395B1 (en) 2001-05-08
HUP9904129A2 (hu) 2000-04-28
AU1198397A (en) 1997-07-17
FR2742660B1 (fr) 1998-04-03
ATE238798T1 (de) 2003-05-15
CA2242224C (fr) 2004-01-13
KR19990076717A (ko) 1999-10-15
EP0868184A1 (fr) 1998-10-07
DE69627880T2 (de) 2004-03-11
NO982738L (no) 1998-08-21
DK0868184T3 (da) 2003-08-25
EA001721B1 (ru) 2001-08-27
NO982738D0 (no) 1998-06-12
EE04045B1 (et) 2003-06-16
WO1997023219A1 (fr) 1997-07-03
NZ324739A (en) 2000-01-28
PL186621B1 (pl) 2004-02-27
PL327567A1 (en) 1998-12-21
EP0868184B1 (fr) 2003-05-02
GEP20022629B (en) 2002-02-25
CA2242224A1 (fr) 1997-07-03
US6383516B1 (en) 2002-05-07
JP2000506500A (ja) 2000-05-30
EE9800197A (et) 1998-12-15
FR2742660A1 (fr) 1997-06-27
AU721949B2 (en) 2000-07-20
CN1207681A (zh) 1999-02-10
NO324680B1 (no) 2007-12-03
BR9612225A (pt) 1999-07-13
DE69627880D1 (de) 2003-06-05
ZA9610776B (en) 1997-06-30
KR100354054B1 (ko) 2003-02-14
HU224214B1 (hu) 2005-06-28
IL125047A0 (en) 1999-01-26
US20020182253A1 (en) 2002-12-05
BG102555A (en) 1999-02-26
PT868184E (pt) 2003-09-30
AR004410A1 (es) 1998-11-04
CN1145488C (zh) 2004-04-14

Similar Documents

Publication Publication Date Title
EA199800593A1 (ru) Микрогранулы с пролонгированным высвобождением, содержащие дилтиазем в качестве активного ингредиента
CA2310585A1 (en) Novel administration form comprising an acid-labile active compound
DE69731498D1 (de) Implantierbares System mit verzögerter Wirkstofffreisetzung
TR200100922T2 (tr) Aktif maddelerin akciğerler yolu ile tatbik edilmesi.
DK0753506T3 (da) 6-Dimethylaminomethyl-1-phenyl-cyclohexanforbindelser som farmaceutisk aktive stoffer
DK0780369T3 (da) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-forbindelser som farmaceutisk virksomme stoffer
EA199900749A1 (ru) Фармацевтическая композиция
EE05620B1 (et) Omeprasooli mikrograanulid, nende valmistamismeetod ja farmatseutilised preparaadid
ATE254846T1 (de) Bodengranulate mit kontrollierter wirkstofffreisetzung (cr-bodengranulate)
FI970530A (fi) Koostumus aktiivisen aineen selektiiviseksi vapauttamiseksi
NO20001847L (no) Ny anvendelse av forbindelser for anti-kløe-aktivitet
DK0653158T3 (da) Fremgangsmåde til mikroindkapsling af i agrikultur aktive midler
DE69518193D1 (de) Präparat mit verzörgerter Wirkstoffabgabe
ATE350021T1 (de) Pharmazeutische formulierung enthaltend trägerkügelchen mit aufgebrachter schicht aus valaciclovir
EP1008345A4 (en) ANTI-ALLERGIC AGENTS
DK524489D0 (da) Fremgangsmaade til fremstilling af biologisk aktive forbindelser, specielt enzymer
CA2224565A1 (en) Agent for combating parasites in farmed fish
NL1002261C2 (nl) Postduivenring.
NZ337208A (en) sustained release pharmaceutical composition containing both slow release and fast release mini-granules coated with dexfenfluramine
ZA966915B (en) Active compound combinations of pyrethriods and insect development inhibitors.
WO2001021765A3 (en) METHOD FOR THE SELECTIVE PROTECTION OF PROLIFERATING NORMAL CELLS AND THE SELECTIVE ERADICATION OF TUMOR CELLS HAVING AN INACTIVE p53 PATHWAY
AU7095196A (en) Alpha-alkoxyiminobenzyl heterocyclic derivatives, intermediates for preparing the same, and agricultural chemicals containing the same as active ingredient
AU5032999A (en) Utilization of substituted o-alkyl-carbamates for combating animal pests
NO892292D0 (no) Fremgangsmaate for fremstilling av overflateaktive forbindelser.
CA2217943A1 (fr) G & g protege pantalon

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AZ KG TJ TM

MK4A Patent expired

Designated state(s): AM BY KZ MD RU